REGISTER NOW
SUBMIT ABSTRACT
7th World Cancer Congress - 2022 | Bangalore 2nd Global Surgery Summit - 2022 | Bangkok | Thailand 7th World Cancer Congress - 2022 | Bangalore
Early Bird Registration Closes: 11th June, 2022, 1st Phase Abstract Submission Closes: 27th January, 2023

MARKET ANALYSIS

The Cardio vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019 at a CAGR of 6.8.market growth can be attributed to the rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular disease approval of new and advanced products and the growing preference for minimally invasive surgeries the Asia Pacific is going to register the highest growth rate in the peripheral vascular devices market during the forecast period the global diagnostic catheters market is expected to reach USD 4302.3 million by 2021, at a CAGR of 7.3 from 2016 the Asia Pacific holds significant growth opportunities’ for market players.
The American interventional cardiology market is currently valued at nearly $1.4 billion. Across most of the market, certain devices, such as FFR guide wires and OCT catheters, are expected to exhibit strong growth over the next several years. The increasing incidence of cardiovascular diseases and the growing geriatric population are the most significant factors driving the growth of the global cardiovascular devices market.
According to the Cardiology Associations, every year, cardiovascular disease (CVD) causes 3.9 million deaths in America and over 1.8 million deaths in the European Union (EU). Furthermore, other factors such as the rapid technological advances, increasing awareness of the population, and high preference of minimally invasive procedures are also supplementing the market growth.
The worldwide fair for interventional cardiology tools touched an estimated $12.2 billion in 2014. According to a new study by Smithers Apex – The Future of Coronary Artery Disease Healing Devices to 2021 – it will raise to $22.5 billion (€20.9 billion) by 2021, with a year-on-year increase of 9.1%.Response for coronary artery disease medical expedients will grow through 2021 as clinically viable and cost-effective solutions are developed. The statement covers three major divisions of cardiology surgery, devices and medications market which includes surgeries, devices and drugs. Cardiac diseases are the number one cause of death universally. Some of the major CVDs include coronary core diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading source of death followed by strokes. The prevalence and incidence rate of core diseases are on a rise; especially in major emerging countries such as India, China and Japan. The market of cardiology surgery, devices and medications are also on a rise.
Cardiac disease is the major reason of death across the world. It assessed that for 17.3 million passing in 2015 and is further predicted to claim 23.6 million survives in 2030 (according to estimation by the World Health Organization). The International Diabetes Federation has valuing that approximately 415 million people were diabetic in 2015 while the number is predictable to increase 642 million universal by 2040. The advanced cardiac intervention market provides dealing choice for a series of cardiovascular diseases which consist of coronary artery disease, heart valve disease, and peripheral vascular disease, among others. The growth in geriatric population wide-reaching has resulted in an increased prevalence of the disease. Moreover, change in eating habits, increased pressure, smoking, and alcohol consumption, and disturbed sleeping patterns are some of the key issues subsidizing to the deteriorating health conditions and to the rise in lasting diseases such as diabetes and cardiac diseases
SCOPE AND IMPORTANCE
A planned overview of patients with valvular coronary illness (VHD):
  • Coronary angiography was utilized as a part of 85.2% of patients before mediation.
  • The Euro Heart Survey (EHS) program has been started request to give quantitative data on cardiovascular sickness.
  • To keep the occurrence of cardiovascular (CV) infection, by executing procedures to lessen the weight of CV hazard elements and frequency of CV illness, and create proper models for solid CV way of life
Greatest Achievements in the Field of Cardiology:
  • Electrocardiography
  • Cardiac catheterization
  • Coronary angiography
  • Cardiovascular surgery
  • Invasive cardiology
  • The coronary care unit
  • Cardiovascular drugs
  • Preventive cardiology
  • Echocardiography
  • Pacemakers and internal defibrillators


7th World Congress on Drug Discovery and Development - 2022 | Bangalore

CONTACT US AT

Conference Secretariat
UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US


INDIA
ARJYOPA HEALTHCARE
#2 RBC Road, Dumdum
Kolkata - 700028, West Bengal, India

WRITE TO US


7th World Cancer Congress - 2022 | Bangalore




SUBMIT ABSTRACT | ONLINE REGISTRATION | CONTACT US | WHO SHOULD ATTEND | WHY ATTEND | FOCUS OF THE CONFERENCE | MARKET ANALYSIS | SPONSOR | KEY TRACKS | CONFERENCE AGENDA | VENUE | WERNER FORRSSMANN AWARD | WILLEM EINTHOVEN AWARD | ALEXIS CARREL AWARD
_______________________________________________________________________________________________________________________

MAIL US AT
Sponsorship/Exhibitions: [email protected]
General Enquiries: [email protected]

______________________________________________________________________________________

[email protected], Arjyopa Healthcare. All Right Reserved